tiprankstipranks
Trending News
More News >
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market

Enanta Pharmaceuticals (ENTA) Income Statement

Compare
190 Followers

Enanta Pharmaceuticals Income Statement

Last quarter (Q1 2026), Enanta Pharmaceuticals's total revenue was $18.61M, an increase of 9.76% from the same quarter last year. In Q1, Enanta Pharmaceuticals's net income was $-11.94M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 65.32M$ 67.64M$ 79.20M$ 86.16M$ 97.07M
Gross Profit
$ 60.74M$ 67.64M$ 79.20M$ 86.16M$ 97.07M
Operating Expenses
$ 146.09M$ 189.33M$ 216.41M$ 210.00M$ 206.65M
Depreciation and Amortization
$ 5.09M$ 2.34M$ 2.37M$ 2.97M$ 3.33M
EBITDA
$ -70.78M$ -104.51M$ -123.48M$ -119.22M$ -104.25M
Operating Income
$ -85.35M$ -121.69M$ -137.21M$ -123.84M$ -109.57M
Other Income/Expenses
$ 1.80M$ 3.90M$ 6.21M$ 1.66M$ 1.99M
Pretax Income
$ -83.55M$ -117.79M$ -131.00M$ -122.19M$ -107.58M
Net Income
$ -81.89M$ -116.05M$ -133.82M$ -121.75M$ -79.00M
Per Share Metrics
Basic EPS
$ -3.84$ -5.48$ -6.38$ -5.91$ -3.92
Diluted EPS
$ -3.84$ -5.48$ -6.38$ -5.91$ -3.92
Weighted Average Shares Outstanding
21.34M 21.16M 20.97M 20.60M 20.17M
Weighted Average Shares Outstanding (Diluted)
21.34M 21.16M 20.97M 20.60M 20.17M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History